Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Canada.
Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
Bone Joint J. 2020 Dec;102-B(12):1723-1734. doi: 10.1302/0301-620X.102B12.BJJ-2020-1125.R1.
The purpose of this study was to: review the efficacy of the induced membrane technique (IMT), also known as the Masquelet technique; and investigate the relationship between patient factors and technique variations on the outcomes of the IMT.
A systematic search was performed in CINAHL, The Cochrane Library, Embase, Ovid MEDLINE, and PubMed. We included articles from 1 January 1980 to 30 September 2019. Studies with a minimum sample size of five cases, where the IMT was performed primarily in adult patients (≥ 18 years old), in a long bone were included. Multivariate regression models were performed on patient-level data to determine variables associated with nonunion, postoperative infection, and the need for additional procedures.
A total of 48 studies were included, with 1,386 cases treated with the IMT. Patients had a mean age of 40.7 years (4 to 88), and the mean defect size was 5.9 cm (0.5 to 26). In total, 82.3% of cases achieved union after the index second stage procedure. The mean time to union was 6.6 months (1.4 to 58.7) after the second stage. Our multivariate analysis of 450 individual patients showed that the odds of developing a nonunion were significantly increased in those with preoperative infection. Patients with tibial defects, and those with larger defects, were at significantly higher odds of developing a postoperative infection. Our analysis also demonstrated a trend towards the inclusion of antibiotics in the cement spacer having a protective effect against the need for additional procedures.
The IMT is an effective management strategy for complex segmental bone defects. Standardized reporting of individual patient data or larger prospective trials is required to determine the optimal implementation of this technique. This is the most comprehensive review of the IMT, and the first to compile individual patient data and use regression models to determine predictors of outcomes. Cite this article: 2020;102-B(12):1723-1734.
本研究旨在:回顾诱导膜技术(IMT),又称 Masquelet 技术的疗效;并探讨患者因素与技术变化对 IMT 结果的关系。
系统检索 CINAHL、Cochrane 图书馆、Embase、Ovid MEDLINE 和 PubMed 中的文献。我们纳入了 1980 年 1 月 1 日至 2019 年 9 月 30 日发表的文章。纳入的研究至少纳入了 5 例患者,IMT 主要应用于成年患者(≥18 岁)的长骨,且纳入的研究均使用了多变量回归模型,以确定与骨不连、术后感染和需要额外手术相关的变量。
共纳入 48 项研究,共纳入 1386 例采用 IMT 治疗的患者。患者的平均年龄为 40.7 岁(4 岁至 88 岁),平均缺损大小为 5.9cm(0.5cm 至 26cm)。总的来说,在索引二期手术后,82.3%的病例达到了愈合。二期手术后,平均愈合时间为 6.6 个月(1.4 至 58.7 个月)。我们对 450 名患者的多变量分析显示,术前感染的患者发生骨不连的几率明显增加。胫骨缺损患者和缺损较大的患者发生术后感染的几率明显更高。我们的分析还表明,在水泥间隔器中加入抗生素有预防需要额外手术的趋势。
IMT 是治疗复杂节段性骨缺损的有效治疗策略。需要进行标准化的个体患者数据报告或更大的前瞻性试验,以确定该技术的最佳实施方法。这是对 IMT 最全面的综述,也是第一个编译个体患者数据并使用回归模型来确定结果预测因素的综述。引用本文:2020;102-B(12):1723-1734。